- Home
- PFLT vs SNN Comparison
PFLT vs SNN Comparison
Compare PFLT & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFLT
- SNN
- Stock Information
- Founded
- PFLT 2010
- SNN 1856
- Country
- PFLT United States
- SNN United Kingdom
- Employees
- PFLT N/A
- SNN N/A
- Industry
- PFLT Finance: Consumer Services
- SNN Industrial Specialties
- Sector
- PFLT Finance
- SNN Health Care
- Exchange
- PFLT Nasdaq
- SNN Nasdaq
- Market Cap
- PFLT 838.8M
- SNN 12.4B
- IPO Year
- PFLT N/A
- SNN 1999
- Fundamental
- Price
- PFLT $11.46
- SNN $29.44
- Analyst Decision
- PFLT Strong Buy
- SNN Strong Buy
- Analyst Count
- PFLT 2
- SNN 1
- Target Price
- PFLT $12.00
- SNN N/A
- AVG Volume (30 Days)
- PFLT 635.8K
- SNN 674.7K
- Earning Date
- PFLT 11-25-2024
- SNN 08-01-2024
- Dividend Yield
- PFLT 10.71%
- SNN 2.55%
- EPS Growth
- PFLT N/A
- SNN 39.77
- EPS
- PFLT 1.60
- SNN 0.35
- Revenue
- PFLT $166,565,000.00
- SNN $5,642,000,000.00
- Revenue This Year
- PFLT $29.07
- SNN $6.92
- Revenue Next Year
- PFLT $14.55
- SNN $5.43
- P/E Ratio
- PFLT $7.18
- SNN $41.81
- Revenue Growth
- PFLT 25.81
- SNN 5.48
- 52 Week Low
- PFLT $9.69
- SNN $21.53
- 52 Week High
- PFLT $12.63
- SNN $31.72
- Technical
- Relative Strength Index (RSI)
- PFLT 43.78
- SNN 46.87
- Support Level
- PFLT $11.67
- SNN $28.26
- Resistance Level
- PFLT $11.90
- SNN $29.64
- Average True Range (ATR)
- PFLT 0.14
- SNN 0.36
- MACD
- PFLT -0.01
- SNN 0.05
- Stochastic Oscillator
- PFLT 6.32
- SNN 58.65
About PFLT PennantPark Floating Rate Capital Ltd.
PennantPark Floating Rate Capital Ltd is a closed-end, externally managed, non-diversified investment company. Its investment objectives are to generate current income and capital appreciation by investing in Floating Rate Loans and other investments made to U.S. middle-market companies. The company believes that Floating Rate Loans to U.S. middle-market companies offer attractive risk-reward to investors due to the limited amount of capital available for such companies and the potential for rising interest rates. The company generate revenue in the form of interest income on the debt securities and dividends.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.